(18f) Fluorocholine Biont

Fluorocholine (18F) Chloride is a radiopharmaceutical agent used in PET imaging for detecting prostate cancer. It is administered intravenously and helps visualize metabolic activity in tissues. This product is intended for diagnostic purposes only.

Fluorocholine (18F) Chloride is primarily used in positron emission tomography (PET) scans to identify prostate cancer and assess its spread. It may also assist in evaluating parathyroid gland disorders. This radiotracer helps clinicians detect areas of abnormal metabolic activity.

After intravenous administration, Fluorocholine (18F) Chloride is rapidly distributed in the body, with uptake in tissues showing metabolic activity. The radiotracer emits positrons that are detected by the PET scanner, creating detailed images for diagnostic evaluation.

This product should only be handled by trained medical professionals in a controlled clinical setting. Patients may be advised to avoid strenuous activity before the scan. Hydration is typically recommended to aid in radiotracer distribution and clearance.

No significant drug interactions are reported with Fluorocholine (18F) Chloride. However, patients should disclose all medications, supplements, and recent medical procedures to their healthcare provider. Certain conditions or medications may require adjustments to imaging protocols.